Category: Testing
280 cases of Delta variant with N501Y, some with E484K too
Delta + Alpha + Beta + Gamma recombinant variant found in Turkey. More...
Sinovac vaccine produces ten times fewer antibodies than Pfizer
A study conducted in Hong Kong on more than a thousand patients shows that the Coronavac vaccine, developed by the Chinese laboratory Sinovac, causes the production of ten times less antibodies than the vaccine developed by BioNTech and produced by Pfizer. More...
Iceland: no herd immunity from vaccines with 50% vaccine breakthrough for hospitalizations
Iceland’s Chief Epidemiologist Þórólfur Guðnason says vaccination has not led to the herd immunity that experts hoped for. More...
USA: B.1.621 now at 10% of Covid-19 sequences in South Florida
Carlos Migoya, CEO of Jackson Health, revealed that now 10% of COVID-positive patients whose results are being sequenced at the University of Miami’s pathology lab have a strain [B.1.621] that originated out of Colombia. More...
Preprint: Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
In this study, we reported the emergence and spread of the novel B.1.621 lineage of SARS-CoV-2, a new VOI with the insertion 146N and several amino acid substitutions in the Spike protein (T95I,Y144T, Y145S, R346K, E484K, N501Y and P681H). More...
Iceland: 70% vaccine breakthrough – 1,565 infections of which 1,091 are fully vaccinated
Iceland’s Covid dashboard confirms the vaccine breakthrough rate in that country is about 70% for infections, as per the information given below. More...
USA, Maryland: “I went to a party with 14 other vaccinated people; 11 of us got COVID”
I’m an epidemiologist at a major medical research university.
USA: Washington State Vaccine Breakthroughs by Variant up to 4th August 2021
This week’s update from Washington State showing vaccine breakthrough cases and which Sars-CoV-2 variant is causing them up to 4th August 2021. More...
Preprint: C.37 Lambda variant exhibits higher infectivity and immune resistance
“In this study, we demonstrated that three mutations, the RSYLTPGD246-253N, L452Q and F490S mutations, respectively confer resistance to the vaccine-induced antiviral immunity. More...
China: Sars-CoV-2 returns to Wuhan
Authorities in the Chinese city of Wuhan will begin testing its entire population, after a handful of positive coronavirus cases were detected there.









